全文获取类型
收费全文 | 1165篇 |
免费 | 66篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 51篇 |
妇产科学 | 4篇 |
基础医学 | 138篇 |
口腔科学 | 22篇 |
临床医学 | 60篇 |
内科学 | 361篇 |
皮肤病学 | 10篇 |
神经病学 | 38篇 |
特种医学 | 135篇 |
外科学 | 132篇 |
综合类 | 64篇 |
预防医学 | 41篇 |
眼科学 | 29篇 |
药学 | 62篇 |
中国医学 | 2篇 |
肿瘤学 | 91篇 |
出版年
2023年 | 3篇 |
2022年 | 10篇 |
2021年 | 14篇 |
2020年 | 11篇 |
2019年 | 13篇 |
2018年 | 17篇 |
2017年 | 17篇 |
2016年 | 30篇 |
2015年 | 31篇 |
2014年 | 31篇 |
2013年 | 33篇 |
2012年 | 32篇 |
2011年 | 30篇 |
2010年 | 38篇 |
2009年 | 45篇 |
2008年 | 43篇 |
2007年 | 47篇 |
2006年 | 55篇 |
2005年 | 49篇 |
2004年 | 48篇 |
2003年 | 27篇 |
2002年 | 43篇 |
2001年 | 53篇 |
2000年 | 43篇 |
1999年 | 47篇 |
1998年 | 47篇 |
1997年 | 38篇 |
1996年 | 45篇 |
1995年 | 22篇 |
1994年 | 24篇 |
1993年 | 23篇 |
1992年 | 15篇 |
1991年 | 18篇 |
1990年 | 17篇 |
1989年 | 23篇 |
1988年 | 35篇 |
1987年 | 24篇 |
1986年 | 16篇 |
1985年 | 28篇 |
1984年 | 9篇 |
1983年 | 9篇 |
1982年 | 3篇 |
1981年 | 4篇 |
1980年 | 5篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1975年 | 6篇 |
1974年 | 2篇 |
排序方式: 共有1241条查询结果,搜索用时 0 毫秒
1.
2.
T. Terada K. Miyamoto G. Hyotani M. Tsuura Y. Nakamura T. Nishiguchi T. Itakura S. Hayashi N. Komai 《Acta neurochirurgica》1992,118(3-4):108-111
Summary Changes in tumour blood flow under an induced hypertensive state were examined in malignant brain tumours to know if the precondition for the effectiveness of induced hypertensive chemotherapy — relative increase in tumour blood flow — are fulfilled. Tumour blood flow was measured under both a resting and an induced hypertensive state in 12 patients with various malignant brain tumours (6 gliomas, 6 metastatic brain tumours) using xenon-enhanced computed tomography. The blood pressure was elevated 40% above the systemic blood pressure of the resting state by the infusion of angiotensin II. Tumour blood flow increased 30% on average above the normal brain tissue blood flow after the induction of an induced hypertensive state (p < 0.05). The tumour blood flow increased in 11 cases of malignant tumours, but decreased in one case with massive brain oedema after induced hypertension. The increase in blood flow was higher in hypervascular tumours and less in hypovascular tumours. Therefore, induced hypertensive chemotherapy probably will be more effective in hypervascular malignant brain tumours with small mass effects. 相似文献
3.
4.
5.
6.
7.
8.
Boxall S Stanton T Hirai K Ward V Yasui T Tahara H Tamori A Nishiguchi S Shiomi S Ishiko O Inaba M Nishizawa Y Dawes R Bodmer W Beverley PC Tchilian EZ 《Human molecular genetics》2004,13(20):2377-2384
The CD45 antigen is a haemopoietic cell specific tyrosine phosphatase essential for antigen receptor mediated signalling in lymphocytes. Expression of different patterns of alternatively spliced CD45 isoforms is associated with distinct functions. We recently identified a polymorphism in exon 6 (A138G) of the gene encoding CD45 (PTPRC) that results in altered CD45 splicing. The 138G allele is present at a high frequency among Japanese (23.7%), with 5.1% individuals homozygous for the G allele. In this study we show that the A138G polymorphism is the cause of altered CD45 isoform expression, promoting splicing towards low molecular weight CD45 isoforms. We further report that the frequency of A138G heterozygotes is significantly reduced in number in cohorts of patients with autoimmune Graves' disease or hepatitis B infection, whereas G138G homozygotes are absent from a cohort of Hashimoto's thyroiditis patients. We also show that 138G individuals exhibit altered cytokine production in vitro and an increased proportion of memory T cells. These data suggest that the 138G variant allele strongly influences these diseases by modulation of immune mechanisms and may have achieved its high frequency as a result of a natural selection probably related to pathogen resistance. 相似文献
9.
10.
Masaru Enomoto Akihiro Tamori Madoka Toyama Kohmoto Takehiro Hayashi Hisato Jomura Daiki Habu Hiroki Sakaguchi Tadashi Takeda Norifumi Kawada Shuichi Seki Susumu Shiomi Noritoshi Koh Shuhei Nishiguchi 《Journal of interferon & cytokine research》2007,27(3):201-207
Sequential treatment with lamivudine and interferon (IFN) has induced sustained biochemical and virologic responses in the majority of patients with chronic hepatitis B in France. However, the efficacy of sequential treatment in patients with chronic hepatitis B virus (HBV) genotype C infection has not been evaluated. Twenty-four HBe antigen-positive patients were treated with 100 mg lamivudine alone for 16-32 weeks, then with both 6 MU IFN-beta and lamivudine for 4 weeks, and lastly with IFN-beta alone for 20 weeks. Sustained response was achieved in 7 (29%) patients 24 weeks after the end of therapy. No lamivudine-resistant variants emerged in any patient. Hepatitis flare occurred in 3 patients after the withdrawal of lamivudine, but none had decompensation. The patients with sustained response were significantly younger at baseline (p = 0.033) and had a significantly lower HBV DNA level at the start of IFN (p = 0.020) than those without sustained response. In conclusion, the rate of response to sequential therapy with lamivudine and IFN in HBe antigen-positive patients with HBV genotype C infection was lower than the rate reported previously. Patients who were young or who had a favorable virologic response to lamivudine were more likely to have a sustained response. 相似文献